In addition, a smaller proportion of patients using SGLT-2i had renal insufficiency (eGFR <60 mL/min/1.73m2) compared to users of DPP-4i and GLP-1 RA, although SGLT-2i can provide renal benefits in patients with type 2 diabetes. The gene discussed is GLP1R; the disease is Renal insufficiency.